HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ulrich, J. T. Articles by Sanderson, S. D. Search for Related Content PubMed PubMed Citation Articles by Ulrich, J. T. Articles by Sanderson, S. D.

Induction of an Antigen-Specific CTL Response by a Conformationally Biased Agonist of Human C5a Anaphylatoxin as a Molecular Adjuvant¹

J. Terry Ulrich^*, Witold Cieplak^*, Natalii J. Paczkowski, Stephen M. Taylor and Sam D. Sanderson^2,

^* Corixa, Hamilton, MT 59840; Department of Physiology and Pharmacology, University of Queensland, St. Lucia, Australia; and Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198

A conformationally biased decapeptide agonist of human C5a anaphylatoxin (YSFKPMPLaR) was used as a molecular adjuvant in stimulating an Ag-specific CTL response against murine P815S target cells expressing an L^d-restricted CTL epitope of the hepatitis B surface Ag (HBsAg). Groups of BALB/c mice (H-2^d) were immunized with aqueous solutions of the HBsAg CTL epitopes (IPQSLDSWWTSL and IPQSLDSWWTSLRR); the C5a agonist (YSFKPMPLaR); the C5a agonist and HBsAg CTL epitopes admixed (IPQSLDSWWTSL and IPQSLDSWWTSLRR + YSFKPMPLaR); the C5a-active, HBsAg CTL epitope-C5a agonist constructs (IPQSLDSWWTSLYSFKPMPLaR, IPQSLDSWWTSLRRYSFKPMPLaR, and IPQSLDSWWTSLRVRRYSFPMPLaR); a C5a-inactive, reverse-moiety construct (YSFKPMPLaRRRIPQSLDSWWTSL); and a C5a-attenuated, carboxyl-terminal-blocked construct (IPQSLDSWWTSLRRYSFKPMPLaRG). Ag-specific CD8⁺ CTL responses were observed after the secondary boost in the absence of any added adjuvant only in mice that were immunized with C5a-active contructs, IPQSLDSWWTSLRRYSFKPMPLaR and IPQSLDSWWTSLRVRRYSFKPMPLaR. These two C5a-active immunogens contained potential subtilisin-sensitive linker sequences between the HBsAg CTL epitope and the C5a agonist; i.e., a double-Arg (RR) and a furin protease sensitive sequence (RVRR). The introduction of these potentially cleavable sequences may be a method of increasing the likelihood of liberating the CTL epitope from the C5a agonist by intracellular proteases, thereby facilitating entry of the epitope into Ag-processing pathways via an exogenous route.

This article has been cited by other articles:

				K. Kimura, J. P. Goff, M. J. Schmerr, J. R. Stabel, S. Inumaru, and Y. Yokomizo Activation of Immune Cells in Bovine Mammary Gland Secretions by Zymosan-Treated Bovine Serum J Dairy Sci, May 1, 2008; 91(5): 1852 - 1864. [Abstract] [Full Text] [PDF]

				H. Boshra, J. Li, R. Peters, J. Hansen, A. Matlapudi, and J. O. Sunyer Cloning, Expression, Cellular Distribution, and Role in Chemotaxis of a C5a Receptor in Rainbow Trout: The First Identification of a C5a Receptor in a Nonmammalian Species J. Immunol., April 1, 2004; 172(7): 4381 - 4390. [Abstract] [Full Text] [PDF]

				D. Chen, K. F. Weis, Q. Chu, C. Erickson, R. Endres, C. R. Lively, J. Osorio, and L. G. Payne Epidermal Powder Immunization Induces both Cytotoxic T-Lymphocyte and Antibody Responses to Protein Antigens of Influenza and Hepatitis B Viruses J. Virol., December 1, 2001; 75(23): 11630 - 11640. [Abstract] [Full Text]